Merck Says Research Shows Its COVID-19 Pill Works Against SARS-CoV-2 Variants

Reuters (9/29, Beasley) reports, “Laboratory studies show that” Merck’s “experimental oral COVID-19 antiviral drug, molnupiravir, is likely to be effective against known variants of the coronavirus, including the dominant, highly transmissible Delta.” Dat...